Masahide Fukudo

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda et al. · Cancer Chemotherapy and Pharmacology · 2012 · 283 citations · Full text

Medicine, Oncology, Pharmacology +12

Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

Yosuke Togashi, Katsuhiro Masago, Masahide Fukudo et al. · Journal of Thoracic Oncology · 2010 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients

Masahide Fukudo, Ikuko Yano, Atsushi Yoshimura et al. · Pharmacogenetics and Genomics · 2008 · 107 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

Masahide Fukudo, Ikuko Yano, Satohiro Masuda et al. · Clinical Pharmacology & Therapeutics · 2006 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Impact of Genetic Variation in Breast Cancer Resistance Protein (BCRP/ABCG2) on Sunitinib Pharmacokinetics

Tomoyuki Mizuno, Masahide Fukudo, Tomohiro Terada et al. · Drug Metabolism and Pharmacokinetics · 2012 · 93 citations

Medicine, Pharmacokinetics, Pharmacology +14